Peanut Oral Immunotherapy Yields Distinct IgE, IgG4 Profiles in Kids After 5 Years
Yamini Virkud, MD, FAAAI, MPH Credit: UNC Health At least 5 years after the IMPACT study, children who had undergone peanut oral immunotherapy maintained different allergen-specific IgE and IgG4 profiles than children who had taken placebo.1 The study is a late-breaker at the 2025 American Academy of Allergy, Asthma, & Immunotherapy (AAAAI) annual meeting in … Read more